We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Kellanova (K - Free Report) delivered fourth-quarter 2024 results, wherein the top and bottom lines beat the Zacks Consensus Estimate, and earnings grew year over year. Although sales declined year over year, organic sales increased due to improved volumes and price/mix.
This marked another strong quarterly performance, driven by a growth-focused portfolio and effective execution across the organization. With a robust presence in emerging markets, Kellanova achieved better-than-expected sales growth despite tough industry conditions while improving profit margins at a faster pace than expected.
On Aug. 14, 2024, Kellanova unveiled a deal with Mars, Incorporated (a global leader in pet care, snacking and food), per which Mars will acquire Kellanova for $83.50 per share in cash. The transaction is anticipated to close in the first half of 2025, subject to various approvals. Kellanova is not issuing any guidance due to its pending merger with Mars, Incorporated.
Kellanova posted adjusted earnings of 92 cents per share, which increased 17.9% year over year, driven by increased operating profit. On a currency-neutral basis, adjusted earnings per share (EPS) rose 19.2% to 93 cents. The bottom line surpassed the Zacks Consensus Estimate of 82 cents.
Find the latest EPS estimates and surprises on Zacks Earnings Calendar.
The company recorded net sales of $3,124 million, which surpassed the Zacks Consensus Estimate of $3,093 million. However, the top line fell 1.6% year over year. The downside can be attributed to unfavorable currency movements. Organic net sales (excluding currency impacts) grew 7%, driven by improved volumes and price/mix.
Kellanova’s adjusted operating profit increased 14.4% to $448 million while rising 19.9% to $470 million on a currency-neutral basis.
Decoding Kellanova’s Segment-Wise Results
Sales in the North America segment amounted to $1,561 million, down 1.7% year over year due to the adverse price/mix and currency headwinds, partly made up by volume growth. On an organic basis, sales fell 1.5%.
Revenues in the Europe segment totaled $601 million, down 2% year over year due to currency headwinds and soft volumes stemming from category softness. This was partly made up by improved price/mix. Organically, net sales dropped 1.2%.
Revenues in Latin America totaled $303 million, down 7.6% year over year due to currency headwinds, partly made up by the favorable price/mix. Organically, sales ascended 5.5%.
Revenues in the Asia Pacific and the Middle East & Africa segment totaled $659 million, up 2.1% year over year due to improvement in volumes and price/mix, somewhat negated by currency headwinds. Organically, sales jumped 36.4%.
Kellanova Stock: Other Updates
The company ended the reported quarter with cash and cash equivalents of $694 million, long-term debt of $4,998 million and total equity of $3,882 million.
Kellanova generated net cash from operating activities of $1,760 million for the year ended Dec. 28, 2024. Capital expenditures amounted to $628 million, and free cash flow was $1,132 million during this time.
Shares of this Zacks Rank #3 (Hold) company have rallied 10.5% in the past six months compared with the industry’s growth of 5.3%.
The consensus estimate for United Natural’s current financial-year sales and earnings indicates growth of 0.3% and 442.9%, respectively, from the year-ago period’s reported figure.
TreeHouse Foods (THS - Free Report) , a private-brand snacks and beverages company, presently holds a Zacks Rank #2 (Buy). THS delivered a trailing four-quarter earnings surprise of 20.4%, on average.
The Zacks Consensus Estimate for TreeHouse Foods’ full-year 2025 sales and earnings implies growth of 1.2% and 24.9%, respectively, from the year-ago period’s reported figure.
US Foods Holding (USFD - Free Report) , which engages in marketing, sale and distribution of fresh, frozen, and dry food and non-food products, currently carries a Zacks Rank #2. USFD delivered a positive earnings surprise of 3.7% in the last reported quarter.
The consensus estimate for US Foods’ full-year sales and earnings calls for growth of 5.2% and 22.1%, respectively, from the prior-year reported levels.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Kellanova Q4 Earnings Beat, Price/Mix & Volumes Drive Organic Sales
Kellanova (K - Free Report) delivered fourth-quarter 2024 results, wherein the top and bottom lines beat the Zacks Consensus Estimate, and earnings grew year over year. Although sales declined year over year, organic sales increased due to improved volumes and price/mix.
This marked another strong quarterly performance, driven by a growth-focused portfolio and effective execution across the organization. With a robust presence in emerging markets, Kellanova achieved better-than-expected sales growth despite tough industry conditions while improving profit margins at a faster pace than expected.
On Aug. 14, 2024, Kellanova unveiled a deal with Mars, Incorporated (a global leader in pet care, snacking and food), per which Mars will acquire Kellanova for $83.50 per share in cash. The transaction is anticipated to close in the first half of 2025, subject to various approvals. Kellanova is not issuing any guidance due to its pending merger with Mars, Incorporated.
Kellanova Price, Consensus and EPS Surprise
Kellanova price-consensus-eps-surprise-chart | Kellanova Quote
K’s Q4 Performance: Key Insights
Kellanova posted adjusted earnings of 92 cents per share, which increased 17.9% year over year, driven by increased operating profit. On a currency-neutral basis, adjusted earnings per share (EPS) rose 19.2% to 93 cents. The bottom line surpassed the Zacks Consensus Estimate of 82 cents.
Find the latest EPS estimates and surprises on Zacks Earnings Calendar.
The company recorded net sales of $3,124 million, which surpassed the Zacks Consensus Estimate of $3,093 million. However, the top line fell 1.6% year over year. The downside can be attributed to unfavorable currency movements. Organic net sales (excluding currency impacts) grew 7%, driven by improved volumes and price/mix.
Kellanova’s adjusted operating profit increased 14.4% to $448 million while rising 19.9% to $470 million on a currency-neutral basis.
Decoding Kellanova’s Segment-Wise Results
Sales in the North America segment amounted to $1,561 million, down 1.7% year over year due to the adverse price/mix and currency headwinds, partly made up by volume growth. On an organic basis, sales fell 1.5%.
Revenues in the Europe segment totaled $601 million, down 2% year over year due to currency headwinds and soft volumes stemming from category softness. This was partly made up by improved price/mix. Organically, net sales dropped 1.2%.
Revenues in Latin America totaled $303 million, down 7.6% year over year due to currency headwinds, partly made up by the favorable price/mix. Organically, sales ascended 5.5%.
Revenues in the Asia Pacific and the Middle East & Africa segment totaled $659 million, up 2.1% year over year due to improvement in volumes and price/mix, somewhat negated by currency headwinds. Organically, sales jumped 36.4%.
Kellanova Stock: Other Updates
The company ended the reported quarter with cash and cash equivalents of $694 million, long-term debt of $4,998 million and total equity of $3,882 million.
Kellanova generated net cash from operating activities of $1,760 million for the year ended Dec. 28, 2024. Capital expenditures amounted to $628 million, and free cash flow was $1,132 million during this time.
Shares of this Zacks Rank #3 (Hold) company have rallied 10.5% in the past six months compared with the industry’s growth of 5.3%.
3 Solid Bets
United Natural Foods, Inc. (UNFI - Free Report) currently sports a Zacks Rank of 1 (Strong Buy). UNFI delivered a trailing four-quarter earnings surprise of 553.1%, on average. You can see the complete list of today’s Zacks #1 Rank stocks here.
The consensus estimate for United Natural’s current financial-year sales and earnings indicates growth of 0.3% and 442.9%, respectively, from the year-ago period’s reported figure.
TreeHouse Foods (THS - Free Report) , a private-brand snacks and beverages company, presently holds a Zacks Rank #2 (Buy). THS delivered a trailing four-quarter earnings surprise of 20.4%, on average.
The Zacks Consensus Estimate for TreeHouse Foods’ full-year 2025 sales and earnings implies growth of 1.2% and 24.9%, respectively, from the year-ago period’s reported figure.
US Foods Holding (USFD - Free Report) , which engages in marketing, sale and distribution of fresh, frozen, and dry food and non-food products, currently carries a Zacks Rank #2. USFD delivered a positive earnings surprise of 3.7% in the last reported quarter.
The consensus estimate for US Foods’ full-year sales and earnings calls for growth of 5.2% and 22.1%, respectively, from the prior-year reported levels.